Roseburia intestinalis-derived extracellular vesicles alleviate osteoporosis through gut microbiota-regulated histidylleucine via Akt/FOXO1 signaling

{"Osteoporosis":[0],"(OP),":[1],"characterized":[2,94],"by":[3,23,44,86],"reduced":[4],"bone":[5,42,109,160],"mass":[6],"and":[7,14,27,48,81,93,105,127,139,149,158,172],"microarchitectural":[8],"deterioration,":[9],"significantly":[10],"impairs":[11],"patient":[12],"health":[13],"quality":[15],"of":[16,69,107,125,130,181],"life.":[17],"Conventional":[18],"therapies":[19],"are":[20],"often":[21],"limited":[22],"long-term":[24],"safety":[25],"concerns":[26],"adverse":[28],"effects.":[29],"Recent":[30],"studies":[31],"suggest":[32],"that":[33],"extracellular":[34],"vesicles":[35],"(EVs)":[36],"play":[37],"a":[38,55,66,191],"critical":[39],"role":[40],"in":[41,77,115,153,163,176],"remodeling":[43],"promoting":[45],"osteoblast":[46],"differentiation":[47,104,138],"mineralization":[49,106,140],"while":[50],"inhibiting":[51],"osteoclast":[52],"activity,":[53],"offering":[54],"potential":[56,170],"therapeutic":[57,169,193],"avenue":[58],"for":[59,195],"OP.":[60,196],"In":[61],"this":[62],"study,":[63],"we":[64],"observed":[65],"significant":[67],"reduction":[68],"Roseburia":[70],"intestinalis":[71],"(R.intestinalis),":[72],"an":[73],"anaerobic,":[74],"gram-positive":[75],"bacterium,":[76],"both":[78,147],"OP":[79,177],"patients":[80],"ovariectomized":[82],"(OVX)":[83],"model":[84],"rats":[85],"16S":[87],"rRNA":[88],"sequencing.":[89],"We":[90],"successfully":[91],"isolated":[92],"R.intestinalis-derived":[95],"EVs":[96],"(REVs),":[97],"which":[98,185],"were":[99,119,151],"found":[100],"to":[101,121,135],"promote":[102,136],"the":[103,123,128,142,168,182],"human":[108],"marrow":[110],"mesenchymal":[111],"stromal":[112],"cells":[113],"(hBMSCs)":[114],"vitro.":[116],"Mechanistically,":[117],"REVs":[118,148,171],"shown":[120],"enhance":[122],"production":[124],"histidylleucine,":[126],"administration":[129],"histidylleucine":[131,150,175,189],"alone":[132],"was":[133],"sufficient":[134],"hBMSCs":[137],"through":[141,179],"Akt/FOXO1":[143],"signaling":[144],"pathway.":[145],"Furthermore,":[146],"effective":[152],"reversing":[154],"gut":[155],"microbiota":[156],"dysbiosis":[157],"improving":[159],"mineral":[161],"density":[162],"vivo.":[164],"These":[165],"findings":[166],"highlight":[167],"their":[173],"metabolite":[174],"treatment":[178],"modulation":[180],"\\"gut-bone\\"":[183],"axis,":[184],"providing":[186],"insights":[187],"into":[188],"as":[190],"promising":[192],"agent":[194]}

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2026-06-01
DOI
https://doi.org/10.1038/s42003-026-10401-x
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Roseburia intestinalis-derived extracellular vesicles alleviate osteoporosis through gut microbiota-regulated histidylleucine via Akt/FOXO1 signaling

Shukai Yang, Sheng Yu, Peng Li, Liu Y et al.
Communications Biology
Extracellular vesicles in disease
article

Roseburia intestinalis-derived extracellular vesicles alleviate osteoporosis through gut microbiota-regulated histidylleucine via Akt/FOXO1 signaling

Shukai Yang, Sheng Yu, Peng Li, Liu Y, Jiaxu Lu, Jiaxian Chen, J Chen, Jiaqi Chu, Chengshuo Huang, Hao Lin, Jianhao Li
article en

Abstract

Osteoporosis (OP), characterized by reduced bone mass and microarchitectural deterioration, significantly impairs patient health and quality of life. Conventional therapies are often limited by long-term safety concerns and adverse effects. Recent studies suggest that extracellular vesicles (EVs) play a critical role in bone remodeling by promoting osteoblast differentiation and mineralization while inhibiting osteoclast activity, offering a potential therapeutic avenue for OP. In this study, we observed a significant reduction of Roseburia intestinalis (R.intestinalis), an anaerobic, gram-positive bacterium, in both OP patients and ovariectomized (OVX) model rats by 16S rRNA sequencing. We successfully isolated and characterized R.intestinalis-derived EVs (REVs), which were found to promote the differentiation and mineralization of human bone marrow mesenchymal stromal cells (hBMSCs) in vitro. Mechanistically, REVs were shown to enhance the production of histidylleucine, and the administration of histidylleucine alone was sufficient to promote hBMSCs differentiation and mineralization through the Akt/FOXO1 signaling pathway. Furthermore, both REVs and histidylleucine were effective in reversing gut microbiota dysbiosis and improving bone mineral density in vivo. These findings highlight the therapeutic potential REVs and their metabolite histidylleucine in OP treatment through modulation of the "gut-bone" axis, which providing insights into histidylleucine as a promising therapeutic agent for OP.

Communications Biology
Guangdong Medical College (CN), Cell Technology (China) (CN), Affiliated Hospital of Guangdong Medical College Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 9%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.